Celularity (CELU) Stock Statistics & Valuation Metrics

Celularity has a market cap or net worth of $24.67M. The enterprise value is $116.37M.

Market Cap

$24.67M

Enterprise Value

$116.37M

Celularity has 32,450,680 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

32,450,680

Owned by Insiders

13.00%

Owned by Institutions

4.58%

Celularity’s return on equity (ROE) is 2.41 and return on invested capital (ROIC) is -151.11%.

Return on Equity (ROE)

2.41

Return on Assets (ROA)

-0.85

Return on Invested Capital (ROIC)

-151.11%

Return on Capital Employed (ROCE)

-2.31

Revenue Per Employee

230.87K

Profits Per Employee

-797.53K

Employee Count

115

Asset Turnover

0.25

Inventory Turnover

35.16

The current PE Ratio of Celularity is -0.42. Celularity’s PEG ratio is -0.01.

PE Ratio

-0.42

PS Ratio

1.32

PB Ratio

-0.62

Price to FCF

-2.76

Price to Operating Cash Flow

-2.49

PEG Ratio

-0.01

In the last 12 months, Celularity had revenue of 26.55M and earned -91.72M in profits. Earnings per share was -3.59.

Revenue

26.55M

Gross Profit

6.48M

Operating Income

-61.31M

Pretax Income

-91.71M

Net Income

-91.72M

EBITDA

-77.66M

Earnings Per Share (EPS)

-3.59

In the last 12 months, operating cash flow was -8.92M and capital expenditures 0, giving a free cash flow of -8.92M billion.

Operating Cash Flow

-8.92M

Free Cash Flow

-8.92M

Free Cash Flow per Share

-0.31

Celularity pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-36.18%

Earnings Yield

-206.58%

Beta

3.30

52-Week Price Change

-55.03%

50-Day Moving Average

1.29

200-Day Moving Average

1.07

Relative Strength Index (RSI)

36.18

Average Volume (3m)

3.92M

Celularity upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Mar 26, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

―

Celularity as a current ratio of 0.15, with Debt / Equity ratio of -107.46%

Current Ratio

0.15

Quick Ratio

0.15

Debt to Market Cap

0.49

Net Debt to EBITDA

-0.45

Interest Coverage Ratio

-9.08

In the past 12 months, Celularity has paid 3,000 in taxes.

Income Tax

3,000

Effective Tax Rate

-0.00

Celularity EV to EBITDA ratio is -1.66, with an EV/FCF ratio of -6.74.

EV to Sales

3.22

EV to EBITDA

-1.66

EV to Free Cash Flow

-6.74

EV to Operating Cash Flow

-6.74

Celularity has $586.00K in cash and marketable securities with $36.02M in debt, giving a net cash position of -$35.44M billion.

Cash & Marketable Securities

$586.00K

Total Debt

$36.02M

Net Cash

-$35.44M

Net Cash Per Share

-$1.09

Tangible Book Value Per Share

-$1.69

Gross margin is 19.23%, with operating margin of -264.27%, and net profit margin of -245.68%.

Gross Margin

19.23%

Operating Margin

-264.27%

Pretax Margin

-245.66%

Net Profit Margin

-245.68%

EBITDA Margin

-193.88%

EBIT Margin

-230.11%

The average price target for Celularity is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-58.14%

EPS Growth Forecast

47.25%

Smart Score

―

AI Score

44